bleakstar / Shutterstock.com
US politicians have called on the National Institute of Health (NIH) to reveal when it would use its right to make companies license certain patents in order to stop drugs being priced too high.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
National Institute of Health; patents; pharmaceutical industry; 1980 Bayh-Dole Act; Lloyd Doggett
